【摘要】：肝性腦病(hepatic encephalopathy,HE)是一個(gè)復(fù)雜的神經(jīng)精神綜合征,臨床上表現(xiàn)為認(rèn)知、行為和機(jī)能障礙,其與肝衰竭和或門(mén)體靜脈分流有關(guān),主要表現(xiàn)為意識(shí)障礙、行為失常和昏迷。HE是急性和慢性肝臟疾病嚴(yán)重、致死的并發(fā)癥,如不及時(shí)糾正,甚至?xí)＜吧�。肝性腦病的發(fā)病機(jī)制目前公認(rèn)的是氨中毒學(xué)說(shuō),血氨的生成及代謝決定肝性腦病的病情進(jìn)展,治療上主要是解除HE誘因及降血氨等治療來(lái)達(dá)到臨床上的治愈。根據(jù)患者精神狀況、臨床指標(biāo)和一般的意識(shí)狀態(tài)的改變,將HE分為0-4期五個(gè)時(shí)期(west Haven分期),即從輕微的精神改變到深昏迷,其中0期即為MHE,MHE指肝硬化患者在臨床檢查沒(méi)有異常,但出現(xiàn)神經(jīng)心理學(xué)和神經(jīng)生理學(xué)損傷,若MHE不及時(shí)干預(yù)和治療,最終有可能發(fā)展為OHE。臨床上OHE通過(guò)癥狀、體征及血氨等實(shí)驗(yàn)室檢查診斷并不難,MHE因無(wú)神經(jīng)系統(tǒng)臨床表現(xiàn)易漏診、誤診。MHE目前還沒(méi)有一個(gè)統(tǒng)一的診斷標(biāo)準(zhǔn),臨床上需要敏感性高、特異性強(qiáng)的診斷HE方法,MHE由于缺乏典型的臨床表現(xiàn),只能通過(guò)神經(jīng)生理測(cè)驗(yàn)和神經(jīng)心理測(cè)試發(fā)現(xiàn),但會(huì)受到年齡、教育程度、學(xué)習(xí)記憶和不同文化背景、種族及病人合作的影響,不宜單獨(dú)作為MHE的篩選手段。為了解決這些缺點(diǎn),Van der Rijt等人提出了腦電圖光譜分析,并率先指出光譜分析可作為HE的診斷和預(yù)后的指標(biāo),因?yàn)槟X電圖不受復(fù)雜的教育和文化影響,不受心理評(píng)估和病人合作與否的影響,腦電圖已被證明是敏感的、獨(dú)立的HE監(jiān)測(cè)工具。目的:探討輕型肝性腦病患者腦電圖檢查的臨床價(jià)值。材料和方法:對(duì)41例輕型肝性腦病患者進(jìn)行腦電圖檢查,觀察腦電圖V監(jiān)測(cè)HE敏感性及特異性。將41例輕型肝性腦病患者按肝功能Child-pugh分級(jí)分為A、B、C 3組;并按有無(wú)肝性腦病典型的臨床體征分為2組;按臨床相關(guān)指標(biāo)分為5組,分別與相應(yīng)EEG進(jìn)行統(tǒng)計(jì)分析。結(jié)果:(1)輕型肝性腦病的病因中,肝硬化有36例,占87.80%;(2)41例輕型肝性腦病患者的EEG輕微異常有9例(21.95%),輕度異常有27例(65.85%),中度異常有5例(12.20%);(3)41例輕型肝性腦病患者按肝功能Child-pugh分級(jí)分為A、B、C三組,A組8例、B組12例、C組21例,B組與C組差異無(wú)顯著性,A組與B組、C組之間有顯著性差異;(4)AST/ALT比值≥1.2組與1.2組比較腦電圖異常差異無(wú)顯著性;總膽紅素≤34.2組與34.2組比較腦電圖異常差異無(wú)顯著性;白蛋白30組與≤30組比較腦電圖異常差異有顯著性,其中輕微腦電圖異常與輕度腦電圖異常差異有顯著性;(5)PTA80組與≤80組、PTA40組與≤40組比較腦電圖異常差異均無(wú)顯著性;(6)血氨≥60組與60組比較腦電圖異常差異無(wú)顯著性;血氨≥120組與120組比較腦電圖異常差異無(wú)顯著性;(7)有HE臨床體征組與無(wú)HE臨床體征組差異有顯著性,其中輕微HE與輕型HE比較腦電圖異常差異有顯著性。結(jié)論:(1)輕微肝性腦病可出現(xiàn)輕微異常腦電圖波;(2)腦電圖異常程度與肝性腦病分級(jí)呈正相關(guān);(3)腦電圖檢查具有實(shí)用性強(qiáng),操作簡(jiǎn)便等特點(diǎn),可以作為輕型肝性腦病的臨床診斷工具,可以更廣泛應(yīng)用于臨床,提高對(duì)輕型肝性腦病尤其是輕微肝性腦病的診斷率。
[Abstract]:Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome. It is characterized by cognition, behavior and dysfunction. It is associated with liver failure and portosystemic shunt. The main manifestations are disturbance of consciousness, abnormal behavior, and coma.HE, which are acute and slow liver diseases, and are fatal complications, such as untimely correction, The pathogenesis of hepatic encephalopathy is currently recognized as ammonia poisoning theory, the formation and metabolism of blood ammonia determine the progression of hepatic encephalopathy, the treatment is mainly to relieve the HE inducement and blood ammonia treatment to achieve clinical cure. According to the patient's mental condition, clinical index and general consciousness change, HE It is divided into 0-4 stages, five periods (West Haven staging), from mild mental change to deep coma, of which 0 is MHE, and MHE refers to cirrhosis patients with no abnormal clinical examination, but neuropsychological and neurophysiological injuries occur. If MHE does not intervene and treat in time, it may eventually develop into OHE. clinical OHE through symptoms, signs and blood. Laboratory diagnosis of ammonia, such as MHE, is not difficult to diagnose. The misdiagnosis of the clinical manifestations of the nervous system is easy to be missed. The misdiagnosed.MHE has not yet a unified diagnostic standard. The diagnostic HE method with high sensitivity and specificity is needed in clinic. Because of the lack of typical clinical manifestations, MHE can only be found by the psychologic test and neuropsychological test. Age, education, learning, memory, and different cultural backgrounds, the influence of race and patient cooperation should not be used alone as a screening tool for MHE. In order to solve these shortcomings, Van der Rijt et al. Proposed the electroencephalogram spectrum analysis, and took the lead to point out that spectral analysis can be used as an indicator of the diagnosis and prognosis of HE because the electroencephalogram is not subject to complex education. The electroencephalogram has been proved to be a sensitive and independent HE monitoring tool. Objective: To explore the clinical value of electroencephalogram in patients with light hepatic encephalopathy. Objective: To explore the clinical value of electroencephalogram examination in patients with light hepatic encephalopathy. Materials and methods: electroencephalogram examination was carried out in 41 patients with light hepatic encephalopathy, and the sensitivity of electroencephalogram V was observed and the sensitivity of HE was observed and the sensitivity of electroencephalogram was observed. Specificity. 41 cases of light hepatic encephalopathy were divided into A, B, and 3 groups according to the liver function Child-pugh classification, and divided into 2 groups according to the typical clinical signs of hepatic encephalopathy, and divided into 5 groups according to the clinical related indexes. Results: (1) there were 36 cases of liver cirrhosis, 87.80%, and 41 cases of light liver disease. (2) 41 cases of light liver. The mild abnormality of EEG in patients with sexual encephalopathy was 9 (21.95%), mild abnormality in 27 cases (65.85%), moderate abnormality in 5 cases (12.20%); (3) 41 cases of light hepatic encephalopathy were divided into A, B, C three, group A, 8 cases, B group 12, C group 21, there was no significant difference between B group and C group, A group and B group, significant difference; 4) ratio There was no significant difference in electroencephalogram abnormalities between the 1.2 groups and the 1.2 groups; the total bilirubin less than 34.2 groups and the 34.2 groups had no significant difference in electroencephalogram. The differences of abnormal EEG differences between the 30 groups and the 30 groups were significant, and the difference between the mild electroencephalogram and the mild electroencephalogram was significant; (5) group PTA80 and < 80, group PTA40 There was no significant difference in electroencephalogram abnormalities between the 40 groups and the 40 groups. (6) there was no significant difference in electroencephalogram abnormalities between the group of blood ammonia > 60 and the 60 groups. There was no significant difference in electroencephalogram abnormalities between the groups of blood ammonia 120 and the 120 groups. (7) there was a significant difference between the HE clinical sign group and the non HE clinical sign group, in which the slight HE and the light HE were compared to the abnormal electroencephalogram. Conclusion: (1) slight abnormal EEG can be found in mild hepatic encephalopathy; (2) the abnormal degree of electroencephalogram is positively correlated with the classification of hepatic encephalopathy; (3) the electroencephalogram examination is practical and easy to operate. It can be used as a diagnostic tool for light hepatic encephalopathy, and can be more widely used in clinic to improve the light liver nature. The diagnostic rate of encephalopathy, especially for mild hepatic encephalopathy.
【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R575.3

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 邵麗華,孫淑愛(ài),郭冬梅,王淑娥,岳鳳娥,趙麗,馬立憲;肝性腦病患者血清一氧化氮水平的研究[J];山東醫(yī)科大學(xué)學(xué)報(bào);2001年02期

2 黃克力,石振友,張振寧;醫(yī)源性肝性腦病66例報(bào)告[J];山東醫(yī)藥;2002年22期

3 周利民;肝性腦病24例臨床分析[J];瀘州醫(yī)學(xué)院學(xué)報(bào);2002年03期

4 章景賢,向軍,余湊水,黃文勁;單純脾切除所致肝性腦病2例[J];中國(guó)血吸蟲(chóng)病防治雜志;2002年04期

5 江虹;肝性腦病33例臨床研究[J];中國(guó)微生態(tài)學(xué)雜志;2002年06期

6 劉衛(wèi),朱斌,章福彬,許邦福;肝性腦病180例原因分析[J];實(shí)用肝臟病雜志;2004年02期

7 盛吉芳;肝性腦病的治療[J];中華肝臟病雜志;2004年05期

8 曹世忠,馬宏杰;肝性腦病的腦干聽(tīng)覺(jué)誘發(fā)電位58檢測(cè)分析[J];山東醫(yī)藥;2004年31期

9 李瑜元;;肝性腦病研究中的失誤和探討[J];中華醫(yī)學(xué)雜志;2005年38期

10 王宇,樸云峰,許賢姬;肝性腦病的研究進(jìn)展[J];臨床肝膽病雜志;2005年02期

相關(guān)會(huì)議論文 前10條

1 曹榮;胡旭東;阮連國(guó);程海林;李宏杰;徐德翠;黃少平;;瑞苷治療肝性腦病32例療效觀察[A];全國(guó)第2屆中西醫(yī)結(jié)合傳染病學(xué)術(shù)會(huì)議暨國(guó)家中醫(yī)藥管理局第1屆傳染病協(xié)作組會(huì)議論文匯編[C];2008年

2 李政育;;由肝性腦病的臨床談臺(tái)灣地區(qū)肝性腦病的治療原則[A];第四次全國(guó)中西醫(yī)結(jié)合神經(jīng)系統(tǒng)疾病學(xué)術(shù)研討會(huì)論文集[C];2002年

3 趙和平;丁保華;張建設(shè);郭世民;張自然;趙耀州;;結(jié)腸凈化對(duì)肝性腦病干預(yù)的臨床研究[A];第一屆全國(guó)疑難重型肝病大會(huì)、第四屆全國(guó)人工肝及血液凈化學(xué)術(shù)年會(huì)論文集[C];2008年

4 盛吉芳;;肝性腦病診治[A];中華醫(yī)學(xué)會(huì)第十六次全國(guó)病毒性肝炎及肝病學(xué)術(shù)會(huì)議論文匯編[C];2013年

5 劉玉蘭;;中國(guó)肝性腦病診治共識(shí)[A];2013第六屆浙江省消化病學(xué)術(shù)大會(huì)論文匯編[C];2013年

6 蘭晶;;中西醫(yī)結(jié)合治療肝性腦病20例[A];第二十一屆全國(guó)中西醫(yī)結(jié)合消化系統(tǒng)疾病學(xué)術(shù)會(huì)議暨國(guó)家級(jí)中西醫(yī)結(jié)合消化系統(tǒng)疾病新進(jìn)展學(xué)習(xí)班論文匯編[C];2009年

7 劉寶華;;肝性腦病患者的預(yù)見(jiàn)性觀察與護(hù)理[A];中華中醫(yī)藥學(xué)會(huì)脾胃病分會(huì)第十九次全國(guó)脾胃病學(xué)術(shù)交流會(huì)論文匯編[C];2007年

8 祝勝美;馮慧悅;;腦電雙頻指數(shù)用于肝性腦病診斷的研究[A];2009年浙江省麻醉學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2009年

9 程井軍;伊藤一健;山本西司;;核因子-κB與肝性腦病關(guān)系探討[A];全國(guó)第2屆中西醫(yī)結(jié)合傳染病學(xué)術(shù)會(huì)議暨國(guó)家中醫(yī)藥管理局第1屆傳染病協(xié)作組會(huì)議論文匯編[C];2008年

10 李汾香;;中西醫(yī)結(jié)合治療肝性腦病57例療效觀察[A];中華中醫(yī)藥學(xué)會(huì)全國(guó)第十四次肝膽病學(xué)術(shù)會(huì)議論文匯編[C];2010年

相關(guān)重要報(bào)紙文章 前10條

1 錢(qián)亮;易與肝性腦病混淆的疾病[N];農(nóng)村醫(yī)藥報(bào)（漢）;2009年

2 ;患肝性腦病是何病因[N];醫(yī)藥養(yǎng)生保健報(bào);2005年

3 ;肝性腦病的診斷要點(diǎn)[N];農(nóng)村醫(yī)藥報(bào)（漢）;2007年

4 劉英;預(yù)見(jiàn)性護(hù)理防肝性腦病[N];醫(yī)藥養(yǎng)生保健報(bào);2006年

5 高翔;肝性腦病的診斷[N];農(nóng)村醫(yī)藥報(bào)（漢）;2009年

6 ;肝性腦病的治療[N];農(nóng)村醫(yī)藥報(bào)（漢）;2007年

7 首都醫(yī)科大學(xué)附屬北京天壇醫(yī)院消化內(nèi)科 李瑞軍;中藥提取物水蘇糖對(duì)肝性腦病具有預(yù)防作用[N];中國(guó)食品報(bào);2009年

8 魏瑋 陳軍梅 張赤志;乳黃制劑可預(yù)防肝性腦病[N];中國(guó)醫(yī)藥報(bào);2005年

9 劉汶 肖e，

本文編號(hào)：2161169